About BridgeBio Pharma (BBIO)
BridgeBio Pharma, Inc. is a United States-based company, The Company discovers and develops medicines that target well-characterized genetic diseases. The Company’s product platform divided into three key categories: Mendelian, Oncology and Gene ther... Read more
- USD73.55
- USD75.49
- USD73.05
- USD78.59
- 0.90%
- 354M
- 1.75M
- 2.03M
- 15.1B
- 28.10
- 157.40%
Stock News
5 hours ago
Trump suggests his ‘representatives’ will buy $200 billion in mortgage bonds. What it means for mortgage rates.
MarketWatch
yesterday
Jim Cramer says the market rotation is punishing last year’s winners and reviving beaten-down stocks
CNBC
yesterday
NASA to bring ISS Crew-11 astronauts back to Earth earlier than planned after medical situation
CNBC
yesterday
Trump instructs 'representatives' to buy $200 billion in mortgage bonds, aiming to lower rates
CNBC